Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.

Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.
复制标题

DOI:
10.1002/pmic.201000730
复制
发表时间:
2011-12
期刊:
影响因子:
3.4
通讯作者:
Lubman, David M.
Lubman, David M.
中科院分区:
生物学3区
文献类型:
--
作者:
Dai, Lan;He, Jintang;Liu, Yashu;Byun, Jaeman;Vivekanandan, Anuradha;Pennathur, Subramaniam;Fan, Xing;Lubman, David M.

文献摘要

参考文献

被引文献

相似文献

Notch 信号传导已被证明在胶质母细胞瘤 (GBM) 癌症干细胞 (CSC) 中发挥核心作用,我们最近证明,γ-分泌酶抑制剂 (GSI) 阻断 Notch 通路可耗尽 GBM CSC,并在体外和体内阻止肿瘤增殖。为了了解这种转化中涉及的蛋白质组变化,基于全局蛋白质组分析和目标验证阶段,进行了基于剂量依赖性定量质谱(MS)的蛋白质组学研究,其中采用了免疫测定和多反应监测(MRM)测定。由于发现阶段需要进行大量鉴定,因此选择用于确认的推定候选蛋白质构成了挑战。采用多级过滤策略和文献挖掘来沿管道传输最有信心的候选者。我们的结果表明,用 GSI 处理 GBM CSC 会诱导向非致瘤细胞的表型转变,增殖减少、分化增加,以及细胞凋亡增加。我们的数据还表明,葡萄糖代谢受到抑制,NFR2 介导的氧化应激反应减弱,这可能是由于它们与 Notch 信号传导的串扰所致。总体而言,这种基于定量蛋白质组学的剂量依赖性工作补充了我们目前对 GBM CSC 中 GSI 治疗时发生的信号转导事件改变的理解。
Notch Signaling has been demonstrated to have a central role in Glioblastoma (GBM) Cancer Stem Cells (CSCs) and we have demonstrated recently that Notch pathway blockade by γ-secretase inhibitor (GSI) depletes GBM CSCs and prevents tumor propagation both in vitro and in vivo. In order to understand the proteome alterations involved in this transformation, a dose-dependent quantitative mass spectrometry (MS) based proteomic study has been performed based on global proteome profiling and a target verification phase where both Immunoassay and a Multiple Reaction Monitoring (MRM) assay are employed. The selection of putative protein candidates for confirmation poses a challenge due to the large number of identifications from the discovery phase. A multilevel filtering strategy together with literature mining is adopted to transmit the most confident candidates along the pipeline. Our results indicate that treating GBM CSCs with GSI induces a phenotype transformation towards non-tumorigenic cells with decreased proliferation and increased differentiation, as well as elevated apoptosis. Suppressed glucose metabolism and attenuated NFR2-mediated oxidative stress response are also suggested from our data, possibly due to their crosstalk with Notch Signaling. Overall, this quantitative proteomic based dose-dependent work complements our current understanding of the altered signaling events occurring upon the treatment of GSI in GBM CSCs.
DOI: 10.1186/1475-2859-9-9
发表时间: 2010-02-12
影响因子: 6.4
作者:
Gómez-Pastor R;Pérez-Torrado R;Cabiscol E;Ros J;Matallana E
通讯作者: Matallana E
DOI: 10.1158/0008-5472.can-04-1364
发表时间: 2004-10-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Galli, R;Binda, E;Vescovi, A
通讯作者: Vescovi, A
DOI: 10.1074/mcp.m800190-mcp200
发表时间: 2009-03-01
影响因子: 7
作者:
Bendall, Sean C.;Hughes, Chris;Lajoie, Gilles A.
通讯作者: Lajoie, Gilles A.
DOI: 10.1007/s10495-009-0437-4
发表时间: 2010-02-01
期刊: APOPTOSIS
影响因子: 7.2
作者:
Cao, Weidong;Yang, Xiaoliang;Fei, Zhou
通讯作者: Fei, Zhou
DOI: 10.1371/journal.pone.0008560
发表时间: 2010-01-05
期刊: PloS one
影响因子: 3.7
作者:
Betapudi V
通讯作者: Betapudi V